The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1R,5S,6r)-N-(2-(3-methylisoquinolin-1-yl)propan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide ID: ALA3421842
PubChem CID: 86293506
Max Phase: Preclinical
Molecular Formula: C19H23N3O
Molecular Weight: 309.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc2ccccc2c(C(C)(C)NC(=O)[C@H]2[C@@H]3CNC[C@@H]32)n1
Standard InChI: InChI=1S/C19H23N3O/c1-11-8-12-6-4-5-7-13(12)17(21-11)19(2,3)22-18(23)16-14-9-20-10-15(14)16/h4-8,14-16,20H,9-10H2,1-3H3,(H,22,23)/t14-,15+,16+
Standard InChI Key: GSKQCADKMBMWTN-ZSHCYNCHSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
2.3358 -3.5978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -2.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2970 -4.1981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0028 -3.7494 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0028 -5.2502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0366 -5.8499 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3021 -6.0014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4792 -5.3357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3232 -7.3649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5206 -8.0470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6945 -7.3635 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6766 -6.0178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6321 1.3486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4777 -6.3357 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.1839 -6.8557 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
10 2 1 0
2 14 1 0
14 15 1 0
15 16 2 0
17 15 1 6
19 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 18 1 0
12 23 1 0
18 24 1 6
19 25 1 6
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 309.41Molecular Weight (Monoisotopic): 309.1841AlogP: 2.36#Rotatable Bonds: 3Polar Surface Area: 54.02Molecular Species: BASEHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.30CX Basic pKa: 10.96CX LogP: 1.38CX LogD: -1.69Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.91Np Likeness Score: -0.28
References 1. Abdel-Magid AF.. (2015) Treating pain with somatostatin receptor subtype 4 agonists., 6 (2): [PMID:25699156 ] [10.1021/ml500538a ]